Induced Pluripotent Stem Cells Market is estimated to be US$ 3.9 billion by 2034; Growing Prevalence of Diseases and Demand for Therapies to Foster Industrial Growth

The Induced Pluripotent Stem Cells (iPSC) are new type of pluripotent cells which are developed by reprogramming human and animal differentiated cells. Neurons for treating neurological disorders, blood cells for creating new blood free of cancer cells and beta islet cells for treating diabetes are some examples of Induced Pluripotent Stem Cells.

Wide benefits of stem-cell based therapies and growing investment in stem-cell based research & development activities has contributed in market growth. The capability to generate physiologically similar organoids and to understand virus infection in humans by pathophysiology is expected to propel the demand for Induced Pluripotent Stem Cells market in future.

The report “Induced Pluripotent Stem Cells Market, By Derived Cell Type (Neurons, Fibroblasts, Hepatocytes, Keratinocytes and Others), By Application (Regenerative Medicine, Drug Development, Tissue Engineering, Toxicity Testing, Cell Therapy and Others), By End-Users (Research & Academic Institutes, Hospital & Clinics, Pharmaceutical Companies and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

 Key Highlights:

• In December 2020, REPROCELLS Inc., launched new personalized induced pluripotent stem cells production service with new B2C website ‘Personal iPS' for its consumers. New launched ‘Personal iPS' service includes provides various advantages such as painless collection of tissues, use of foot-print-free mRNA technology for highest quality of iPSCs creation.

Analyst View:

As Induced Pluripotent Stem Cells provides safer & greater drug development platforms the target market is likely to expand with huge growth. Growing prevalence of diseases and wide benefits of iPSCs has driven market growth. Robust product pipeline and presence of major players has powered the demand for Induced Pluripotent Stem Cells market growth. As a result, market competition is intensifying, and both big international corporations and start-ups are vying to establish position in the market.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Induced Pluripotent Stem Cells Market, By Derived Cell Type (Neurons, Fibroblasts, Hepatocytes, Keratinocytes and Others), By Application (Regenerative Medicine, Drug Development, Tissue Engineering, Toxicity Testing, Cell Therapy and Others), By End-Users (Research & Academic Institutes, Hospital & Clinics, Pharmaceutical Companies and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

Key Market Insights from the report:

Induced Pluripotent Stem Cells Market accounted for US$ 2 billion in 2024 and is estimated to be US$ 3.9 billion by 2034 and is anticipated to register a CAGR of 6.80%. The Induced Pluripotent Stem Cells Market is segmented based on Derived Cell Type, Application, End-Users and Region.

• Based on Derived Cell Type, Induced Pluripotent Stem Cells Market is segmented into Neurons, Fibroblasts, Hepatocytes, Keratinocytes and Others.
• Based on Application, Induced Pluripotent Stem Cells Market is segmented into Regenerative Medicine, Drug Development, Tissue Engineering, Toxicity Testing, Cell Therapy and Others.
• Based on End-Users, Induced Pluripotent Stem Cells Market is segmented into Research & Academic Institutes, Hospital & Clinics, Pharmaceutical Companies and Others.
• By Region, the Induced Pluripotent Stem Cells Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Competitive Landscape & their strategies of Induced Pluripotent Stem Cells Market:

The prominent players operating in the Induced Pluripotent Stem Cells Market includes, Lonza, Evotec SE, Thermo Fisher Scientific Inc., Axol Bioscience Ltd., Merck KGaA, Fate Therapeutics, Hitachi Ltd., Cynata Therapeutics Limited, Applied StemCells Inc., REPROCELLS Inc., and others.

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- [email protected]

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com